Pharmaceutical go-to-market transformation has become the industry's most urgent priority, yet cross-functional coordination remains pharma's biggest challenge.
The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by granting Medicare the authority to negotiate prices for certain high-co
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
